# Widepoint Corp: overview WYY · NYSE · CIK 1034760 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/wyy.md) · [Financials](/companies/wyy/financials.md) · [Filings](/companies/wyy/filings.md) · [Insiders](/companies/wyy/insiders.md) Latest reported revenue: [$38.0m](/filings/0001654954-26-007588.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:Revenues, accession 0001654954-26-007588). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [34.6](/filings/0001654954-25-012988.md) | [37.7 d](/filings/0001654954-26-002749.md) | [33.5](/filings/0001654954-26-004889.md) | [37.3](/filings/0001654954-26-007588.md) | [36.1](/filings/0001654954-25-012988.md) | [42.3 d](/filings/0001654954-26-002749.md) | [40.6](/filings/0001654954-26-004889.md) | [38.0](/filings/0001654954-26-007588.md) | | Gross margin | % | [13.6%](/filings/0001654954-25-012988.md) | [12.6% d](/filings/0001654954-26-002749.md) | [14.3%](/filings/0001654954-26-004889.md) | [13.7%](/filings/0001654954-26-007588.md) | [14.6%](/filings/0001654954-25-012988.md) | [13.8% d](/filings/0001654954-26-002749.md) | [13.8%](/filings/0001654954-26-004889.md) | [15.4%](/filings/0001654954-26-007588.md) | | Operating margin | % | [(1.3%)](/filings/0001654954-25-012988.md) | [(0.8%) d](/filings/0001654954-26-002749.md) | [(2.4%)](/filings/0001654954-26-004889.md) | [(1.9%)](/filings/0001654954-26-007588.md) | [(1.3%)](/filings/0001654954-25-012988.md) | [(1.9%) d](/filings/0001654954-26-002749.md) | [(0.1%)](/filings/0001654954-26-004889.md) | [0.0%](/filings/0001654954-26-007588.md) | | Net margin | % | [(1.2%)](/filings/0001654954-25-012988.md) | [(0.9%) d](/filings/0001654954-26-002749.md) | [(2.2%)](/filings/0001654954-26-007588.md) | [(1.7%)](/filings/0001654954-26-007588.md) | [(1.5%)](/filings/0001654954-25-012988.md) | [(2.0%) d](/filings/0001654954-26-002749.md) | [0.2%](/filings/0001654954-26-007588.md) | [0.2%](/filings/0001654954-26-007588.md) | | Diluted EPS | $ per share | [(0.04)](/filings/0001654954-25-012988.md) | not reported | [(0.08)](/filings/0001654954-26-004889.md) | [(0.06)](/filings/0001654954-26-007588.md) | [(0.06)](/filings/0001654954-25-012988.md) | not reported | [0.01](/filings/0001654954-26-004889.md) | [0.01](/filings/0001654954-26-007588.md) | | Free cash flow | $m | [1.8 d](/filings/0001654954-25-012988.md) | [2.4 d](/filings/0001654954-26-002749.md) | [(3.3)](/filings/0001654954-26-004889.md) | [3.1 d](/filings/0001654954-26-007588.md) | [5.9 d](/filings/0001654954-25-012988.md) | [(0.3) d](/filings/0001654954-26-002749.md) | [(1.0)](/filings/0001654954-26-004889.md) | [(0.1) d](/filings/0001654954-26-007588.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [87.3](/filings/0001654954-23-003960.md) | [94.1](/filings/0001654954-24-003664.md) | [106](/filings/0001654954-25-004306.md) | [143](/filings/0001654954-26-002749.md) | [151](/filings/0001654954-26-002749.md) | | Gross margin | % | [18.7%](/filings/0001654954-23-003960.md) | [15.5%](/filings/0001654954-24-003664.md) | [14.8%](/filings/0001654954-25-004306.md) | [13.3%](/filings/0001654954-26-002749.md) | [14.0%](/filings/0001654954-26-002749.md) | | Operating margin | % | [0.7%](/filings/0001654954-23-003960.md) | [(20.9%)](/filings/0001654954-24-003664.md) | [(3.5%)](/filings/0001654954-25-004306.md) | [(1.3%)](/filings/0001654954-26-002749.md) | [(1.8%)](/filings/0001654954-26-002749.md) | | Net margin | % | [0.4%](/filings/0001654954-23-003960.md) | [(25.1%)](/filings/0001654954-24-003664.md) | [(3.8%)](/filings/0001654954-25-004306.md) | [(1.4%)](/filings/0001654954-26-002749.md) | [(1.8%)](/filings/0001654954-26-002749.md) | | Diluted EPS | $ per share | [0.04](/filings/0001654954-23-003960.md) | [(2.70)](/filings/0001654954-24-003664.md) | [(0.46)](/filings/0001654954-25-004306.md) | [(0.21)](/filings/0001654954-26-002749.md) | [(0.28)](/filings/0001654954-26-002749.md) | | Free cash flow | $m | [(1.5)](/filings/0001654954-23-003960.md) | [5.8](/filings/0001654954-24-003664.md) | [0.4](/filings/0001654954-25-004306.md) | [1.6](/filings/0001654954-26-002749.md) | [5.5](/filings/0001654954-26-002749.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/wyy/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $7.5m | 426,524 | | New +426,524 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.3m | 360,356 | | Added +3,601 | | [Potomac Capital Management, Inc.](/funds/1418746.md) | 2026-06-30 | $5.2m | 299,162 | | Added +26,382 | | [Focus Partners Wealth](/funds/1542153.md) | 2026-06-30 | $2.7m | 157,046 | | Added +154,791 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $2.1m | 120,321 | | Reduced −3,277 | | [Summit Financial Strategies, Inc.](/funds/1625246.md) | 2026-06-30 | $1.7m | 98,457 | | Reduced −19,291 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $1.7m | 96,924 | | Added +62,259 | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $1.6m | 91,700 | Call | Added +77,900 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $1.6m | 88,742 | | Reduced −6,814 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $1.4m | 77,243 | | Reduced −1,893 | ## Recent filings [All 659 filings](/companies/wyy/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-16 | 20:00 ET | [8-K](/filings/0001654954-26-008985.md) | 5.02 Departure or appointment of officers or directors | 0001654954-26-008985 | | 2026-08-17 | 21:08 ET | [8-K](/filings/0001654954-26-007700.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-007700 | | 2026-08-13 | 20:12 ET | [8-K](/filings/0001654954-26-007590.md) | 5.02 Departure or appointment of officers or directors | 0001654954-26-007590 | | 2026-08-13 | 20:09 ET | [10-Q](/filings/0001654954-26-007588.md) | Quarterly report, period 2026-06-30 | 0001654954-26-007588 | | 2026-06-30 | 12:06 ET | [8-K](/filings/0001654954-26-006330.md) | 7.01 Regulation FD disclosure | 0001654954-26-006330 | | 2026-06-25 | 10:30 ET | [8-K](/filings/0001654954-26-006193.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-26-006193 | | 2026-06-22 | 10:07 ET | [8-K](/filings/0001654954-26-006086.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-26-006086 | | 2026-05-20 | 01:37 ET | [8-K](/filings/0001654954-26-005146.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-005146 | | 2026-05-19 | 12:15 ET | [8-K](/filings/0001654954-26-005090.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-26-005090 | | 2026-05-14 | 20:06 ET | [10-Q](/filings/0001654954-26-004889.md) | Quarterly report, period 2026-03-31 | 0001654954-26-004889 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001654954-26-002749.md), filed Mar 25, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/50a5064c-4440-4899-ba77-9e9741c1ac6f) ## About the filer - CIK: 1034760 - Tickers: WYY - Exchange: NYSE - SIC code: 7373 Services-Computer Integrated Systems Design - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.